Jeffrey Teuteberg, MD
Cardiovascular Disease (Cardiology) · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Teuteberg’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C150673 · Current
Licensed to practise in California · since 2017 · expires 2027-06-30 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$76,854
Medicare paid this office $76,854 for 489 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 122 | $16,352 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $13,839 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $12,091 | $103 |
| Critical care, first 30-74 minutes | 13 | $7,832 | $186 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $5,726 | $117 |
See all 12 services
| Long return visit (40+ min) | 122 | $16,352 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $13,839 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $12,091 | $103 |
| Critical care, first 30-74 minutes | 13 | $7,832 | $186 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $5,726 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $4,740 | $71 |
| Return visit (30+ min) | 27 | $3,718 | $120 |
| Long return visit (40+ min) | 15 | $2,693 | $142 |
| New patient visit (60+ min) | 15 | $2,254 | $150 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,902 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 237 | $1,793 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 24 | $525 | $22 |
Who their Medicare patients are
489 Original Medicare patients in 2024. Average age 72 · Under 65 19% · 85 and older 15% · Women 44% · Also on Medicaid 37% · Health risk score 2.78. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Heart failure 62% · Chronic kidney disease 56% · Coronary heart disease 54% · Diabetes 51% · Atrial fibrillation 51% · Depression 28% · COPD 25% · Cancer 19% · Dementia 17% · Stroke 16%.
The office billed $372,921, Medicare allowed $99,987 and paid $76,854; for 941 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 489 | 941 | 72 | 2.78 | $372,921 | $76,854 |
| 2023 | 488 | 1,119 | 72 | 3.06 | $485,312 | $98,676 |
| 2022 | 359 | 970 | 71 | 2.80 | $412,096 | $85,790 |
| 2021 | 254 | 771 | 69 | 2.97 | $326,776 | $76,747 |
| 2020 | 342 | 870 | 69 | 3.13 | $289,692 | $70,334 |
| 2019 | 237 | 892 | 67 | 3.11 | $321,954 | $71,136 |
| 2018 | 183 | 847 | 66 | 3.37 | $301,007 | $63,950 |
| 2017 | 175 | 491 | 63 | 3.54 | $153,124 | $34,146 |
| 2016 | 220 | 479 | 62 | 2.94 | $131,276 | $34,992 |
| 2015 | 237 | 570 | 61 | 2.89 | $162,136 | $42,526 |
| 2014 | 217 | 501 | 62 | 2.81 | $140,296 | $38,834 |
| 2013 | 323 | 703 | 64 | 2.89 | $200,703 | $51,350 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $30,009 | $110 |
| Long return visit (40+ min) | 129 | $20,895 | $128 |
| Critical care, first 30-74 minutes | 34 | $20,579 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $6,101 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,478 | $154 |
| Return visit (30+ min) | 38 | $3,264 | $84 |
| Evaluation of lower heart chamber assist device | 12 | $3,170 | $36 |
| Hospital discharge day management, 30 minutes or less | 36 | $2,766 | $75 |
| Long return visit (40+ min) | 14 | $2,093 | $140 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 209 | $1,668 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 18 | $455 | $24 |
2022: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $26,915 | $93 |
| Long return visit (40+ min) | 126 | $18,137 | $122 |
| Critical care, first 30-74 minutes | 16 | $12,117 | $195 |
| Return visit (30+ min) | 65 | $5,449 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,222 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,616 | $65 |
| Evaluation of lower heart chamber assist device | 16 | $3,802 | $36 |
| New patient visit (60+ min) | 17 | $2,871 | $169 |
| Hospital discharge day management, 30 minutes or less | 34 | $2,605 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 78 | $646 | $8 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 13 | $298 | $23 |
2021: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $27,765 | $94 |
| Return visit (30+ min) | 94 | $10,332 | $84 |
| Critical care, first 30-74 minutes | 19 | $8,969 | $199 |
| Long return visit (40+ min) | 63 | $8,610 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,783 | $187 |
| New patient visit (60+ min) | 20 | $3,340 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,722 | $66 |
| Hospital discharge day management, 30 minutes or less | 26 | $1,766 | $68 |
| Evaluation of lower heart chamber assist device | 13 | $1,498 | $33 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $407 | $25 |
2020: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $26,764 | $97 |
| Long return visit (40+ min) | 86 | $9,432 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $8,395 | $187 |
| Return visit (30+ min) | 50 | $3,841 | $71 |
| Evaluation of lower heart chamber assist device | 17 | $3,563 | $44 |
| New patient visit (60+ min) | 22 | $3,198 | $145 |
| Hospital discharge day management, 30 minutes or less | 26 | $1,711 | $66 |
| Short return visit (20+ min) | 31 | $1,628 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,353 | $68 |
| Short return visit (20+ min) | 16 | $1,126 | $56 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 38 | $972 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 71 | $596 | $8 |
| Telehealth originating site facility fee | 13 | $362 | $21 |
2019: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $26,637 | $92 |
| Long return visit (40+ min) | 99 | $12,406 | $94 |
| Evaluation of lower heart chamber assist device | 32 | $9,478 | $41 |
| Return visit (30+ min) | 71 | $5,480 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,522 | $181 |
| New patient visit (60+ min) | 20 | $2,786 | $139 |
| Long return visit (40+ min) | 18 | $2,320 | $116 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,703 | $65 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $314 | $24 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $30,427 | $94 |
| Return visit (30+ min) | 116 | $9,856 | $61 |
| Evaluation of lower heart chamber assist device | 34 | $9,500 | $40 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $4,002 | $182 |
| Long return visit (40+ min) | 20 | $1,995 | $100 |
| New patient visit (60+ min) | 14 | $1,890 | $135 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,337 | $67 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $15,412 | $89 |
| Return visit (30+ min) | 90 | $4,773 | $48 |
| Evaluation of lower heart chamber assist device | 26 | $4,356 | $39 |
| Insertion of tube in right heart chambers for measurement | 11 | $949 | $79 |
| Hospital discharge day management, 30 minutes or less | 14 | $859 | $61 |
2016: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $11,135 | $80 |
| Return visit (30+ min) | 97 | $6,490 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,670 | $157 |
| Insertion of tube in right heart chambers for measurement | 23 | $2,497 | $89 |
| Return visit (30+ min) | 13 | $2,212 | $82 |
| Evaluation of lower heart chamber assist device | 18 | $997 | $33 |
| Hospital discharge day management, 30 minutes or less | 13 | $782 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 24 | $296 | $11 |
2015: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $13,966 | $80 |
| Return visit (30+ min) | 90 | $7,004 | $53 |
| Critical care, first 30-74 minutes | 15 | $6,123 | $161 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,315 | $158 |
| Insertion of tube in right heart chambers for measurement | 27 | $2,883 | $90 |
| Evaluation of lower heart chamber assist device | 17 | $1,129 | $31 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $786 | $56 |
| Hospital discharge day management, 30 minutes or less | 13 | $742 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $189 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 19 | $120 | $6 |
2014: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $12,963 | $78 |
| Return visit (30+ min) | 91 | $7,185 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $5,403 | $150 |
| Critical care, first 30-74 minutes | 12 | $3,641 | $173 |
| Insertion of tube in right heart chambers for measurement | 17 | $2,054 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,279 | $56 |
| Hospital discharge day management, 30 minutes or less | 14 | $834 | $56 |
| Evaluation of lower heart chamber assist device | 13 | $573 | $30 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $131 | $9 |
2013: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $14,837 | $77 |
| Critical care, first 30-74 minutes | 23 | $9,218 | $165 |
| Return visit (30+ min) | 103 | $7,555 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $5,840 | $146 |
| Biopsy of heart muscle | 16 | $4,529 | $181 |
| Insertion of tube in right heart chambers for measurement | 21 | $2,535 | $115 |
| Hospital discharge day management, 30 minutes or less | 15 | $811 | $54 |
| Evaluation of lower heart chamber assist device | 11 | $677 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 94 | $588 | $6 |
Medicaid work
$1,913 in 2024
Medicaid paid $1,913 for 224 billed services this clinician did in 2024, up to 124 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 224 | $1,913 |
| 2024 | 224 | 1 | 124 | $1,913 |
| 2023 | 287 | 3 | 103 | $5,278 |
| 2022 | 171 | 4 | 67 | $3,904 |
| 2021 | 63 | 2 | 19 | $2,017 |
| 2020 | 86 | 2 | 33 | $1,741 |
| 2018 | 25 | 1 | 13 | $1,370 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 63 | $2,493 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 208 | $2,198 |
| Long return visit (40+ min) | 16 | $587 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 55 | $1,706 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 87 | $814 |
| Long return visit (40+ min) | 13 | $694 |
| Return visit (30+ min) | 16 | $689 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 47 | $1,137 |
| 1ST HOSP IP/OBS HIGH 75 | 16 | $880 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 31 | $1,073 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 55 | $668 |
2018
| Return visit (30+ min) | 25 | $1,370 |
Drugs they prescribed that Part D paid
$503,548
Pharmacies billed $503,548 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,256) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,901 generic and fewer than 11 brand-name prescriptions · $503,548 in drug cost · 28 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 121 | $159,591 | $1,319 |
| Jardiance | 77 | $102,622 | $1,333 |
| Eliquis | 34 | $44,096 | $1,297 |
| Farxiga | 46 | $37,667 | $819 |
| Everolimus | 13 | $26,155 | $2,012 |
See all 38 drugs
| Entresto | 121 | $159,591 | $1,319 |
| Jardiance | 77 | $102,622 | $1,333 |
| Eliquis | 34 | $44,096 | $1,297 |
| Farxiga | 46 | $37,667 | $819 |
| Everolimus | 13 | $26,155 | $2,012 |
| Zarxio | 11 | $25,991 | $2,363 |
| Sirolimus | 51 | $15,107 | $296 |
| Tacrolimus | 97 | $6,001 | $62 |
| Mycophenolate Mofetil | 47 | $4,083 | $87 |
| Cyclosporine Modified | 14 | $3,215 | $230 |
| Bumetanide | 41 | $2,403 | $59 |
| Rosuvastatin | 174 | $1,953 | $11 |
| Carvedilol | 175 | $1,724 | $10 |
| Potassium Chloride | 58 | $1,442 | $25 |
| Eplerenone | 17 | $1,233 | $73 |
| Spironolactone | 93 | $948 | $10 |
| Ezetimibe | 49 | $870 | $18 |
| Metoprolol | 54 | $847 | $16 |
| Atorvastatin | 89 | $846 | $10 |
| Pantoprazole | 97 | $797 | $8 |
| Losartan | 82 | $593 | $7 |
| Digoxin | 32 | $522 | $16 |
| Furosemide | 64 | $410 | $6 |
| Isosorbide Mononitrate Er | 27 | $403 | $15 |
| Acyclovir | 21 | $402 | $19 |
| Hydralazine | 18 | $324 | $18 |
| Warfarin | 17 | $303 | $18 |
| Lisinopril | 53 | $275 | $5 |
| Tamsulosin | 32 | $268 | $8 |
| Levothyroxine | 47 | $266 | $6 |
| Gabapentin | 27 | $219 | $8 |
| Pravastatin | 26 | $187 | $7 |
| Prednisone | 24 | $158 | $7 |
| Famotidine | 54 | $131 | $2 |
| Amlodipine Besylate | 45 | $131 | $3 |
| Hydroxyzine | 13 | $112 | $9 |
| Sertraline | 20 | $52 | $3 |
| Amoxicillin | 12 | $22 | $2 |
Year by year
| 2024 | 2,256 | 274 | 0% (0) | None | $503,548 |
| 2023 | 1,897 | 290 | None | None | $478,700 |
| 2022 | 2,000 | 281 | None | None | $416,565 |
| 2021 | 2,040 | 265 | 0% (0) | None | $346,367 |
| 2020 | 2,271 | 257 | None | None | $297,251 |
| 2019 | 2,407 | 293 | 0% (0) | None | $349,129 |
| 2018 | 2,017 | 258 | None | 15% | $213,175 |
| 2017 | 2,790 | 290 | None | None | $550,839 |
| 2016 | 3,161 | 242 | None | 16% | $709,093 |
| 2015 | 3,046 | 214 | None | None | $739,903 |
| 2014 | 3,493 | 222 | None | 17% | $786,568 |
| 2013 | 3,489 | 199 | 1% (20) | 17% | $623,747 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Entresto | 108 | $171,310 | $1,586 |
| Eliquis | 57 | $70,376 | $1,235 |
| Jardiance | 46 | $65,258 | $1,419 |
| Farxiga | 28 | $31,657 | $1,131 |
| Everolimus | 24 | $18,069 | $753 |
| Sirolimus | 37 | $16,584 | $448 |
| Repatha Sureclick | 14 | $8,374 | $598 |
| Tacrolimus | 89 | $8,101 | $91 |
| Mycophenolate Mofetil | 28 | $6,378 | $228 |
| Cyclosporine Modified | 17 | $3,833 | $225 |
| Bumetanide | 38 | $2,546 | $67 |
| Potassium Chloride | 54 | $2,511 | $46 |
| Rosuvastatin | 106 | $2,426 | $23 |
| Carvedilol | 154 | $2,316 | $15 |
| Pantoprazole | 93 | $1,833 | $20 |
| Atorvastatin | 93 | $1,672 | $18 |
| Ezetimibe | 39 | $1,651 | $42 |
| Losartan | 81 | $1,575 | $19 |
| Eplerenone | 24 | $1,331 | $55 |
| Metoprolol | 45 | $1,239 | $28 |
| Spironolactone | 80 | $1,093 | $14 |
| Lisinopril | 51 | $1,033 | $20 |
| Famotidine | 37 | $781 | $21 |
| Digoxin | 25 | $573 | $23 |
| Nyamyc | 11 | $550 | $50 |
| Ondansetron | 19 | $510 | $27 |
| Furosemide | 66 | $498 | $8 |
| Amlodipine Besylate | 33 | $449 | $14 |
| Warfarin | 17 | $417 | $25 |
| Levothyroxine | 44 | $394 | $9 |
| Tamsulosin | 34 | $375 | $11 |
| Pravastatin | 22 | $345 | $16 |
| Allopurinol | 16 | $249 | $16 |
| Hydralazine | 14 | $201 | $14 |
| Prednisone | 20 | $164 | $8 |
2022: 41 drugs
| Entresto | 78 | $113,516 | $1,455 |
| Eliquis | 82 | $68,813 | $839 |
| Jardiance | 25 | $30,965 | $1,239 |
| Farxiga | 17 | $27,079 | $1,593 |
| Tacrolimus | 130 | $23,654 | $182 |
| Sirolimus | 65 | $20,239 | $311 |
| Everolimus | 17 | $15,834 | $931 |
| Xarelto | 11 | $13,697 | $1,245 |
| Mycophenolate Mofetil | 18 | $6,341 | $352 |
| Repatha Sureclick | 11 | $6,233 | $567 |
| Bumetanide | 55 | $5,804 | $106 |
| Cyclosporine Modified | 28 | $5,159 | $184 |
| Rosuvastatin | 87 | $3,641 | $42 |
| Carvedilol | 155 | $2,500 | $16 |
| Lisinopril | 63 | $1,955 | $31 |
| Losartan | 106 | $1,899 | $18 |
| Potassium Chloride | 43 | $1,594 | $37 |
| Metoprolol | 49 | $1,529 | $31 |
| Eplerenone | 19 | $1,354 | $71 |
| Spironolactone | 105 | $1,260 | $12 |
| Amlodipine Besylate | 46 | $938 | $20 |
| Atorvastatin | 77 | $904 | $12 |
| Digoxin | 31 | $854 | $28 |
| Pantoprazole | 66 | $816 | $12 |
| Levothyroxine | 45 | $621 | $14 |
| Hydralazine | 17 | $559 | $33 |
| Warfarin | 33 | $503 | $15 |
| Furosemide | 80 | $482 | $6 |
| Ezetimibe | 15 | $443 | $30 |
| Famotidine | 19 | $367 | $19 |
| Tamsulosin | 25 | $342 | $14 |
| Nystatin | 12 | $302 | $25 |
| Allopurinol | 21 | $287 | $14 |
| Isosorbide Mononitrate Er | 13 | $284 | $22 |
| Pravastatin | 13 | $282 | $22 |
| Amiodarone | 11 | $224 | $20 |
| Acyclovir | 12 | $187 | $16 |
| Mirtazapine | 11 | $185 | $17 |
| Omeprazole | 12 | $174 | $14 |
| Gabapentin | 13 | $129 | $10 |
| Amoxicillin | 12 | $32 | $3 |
2021: 44 drugs
| Entresto | 76 | $101,735 | $1,339 |
| Eliquis | 62 | $51,280 | $827 |
| Zortress | 19 | $20,742 | $1,092 |
| Prograf | 16 | $13,048 | $815 |
| Sirolimus | 52 | $12,822 | $247 |
| Everolimus | 13 | $11,555 | $889 |
| Tacrolimus | 44 | $6,834 | $155 |
| Bumetanide | 79 | $6,686 | $85 |
| Febuxostat | 16 | $4,878 | $305 |
| Eplerenone | 20 | $3,803 | $190 |
| Cyclosporine Modified | 22 | $3,741 | $170 |
| Potassium Chloride | 58 | $2,619 | $45 |
| Rosuvastatin | 79 | $2,436 | $31 |
| Losartan | 108 | $2,304 | $21 |
| Carvedilol | 149 | $2,122 | $14 |
| Mycophenolate Mofetil | 14 | $1,947 | $139 |
| Midodrine | 11 | $1,556 | $141 |
| Metoprolol | 55 | $1,455 | $26 |
| Megestrol Acetate | 11 | $1,150 | $105 |
| Levothyroxine | 68 | $1,077 | $16 |
| Pantoprazole | 63 | $1,047 | $17 |
| Lisinopril | 75 | $982 | $13 |
| Ezetimibe | 19 | $973 | $51 |
| Spironolactone | 87 | $926 | $11 |
| Amlodipine Besylate | 55 | $819 | $15 |
| Atorvastatin | 58 | $805 | $14 |
| Digoxin | 24 | $758 | $32 |
| Torsemide | 13 | $644 | $50 |
| Hydralazine | 32 | $560 | $18 |
| Furosemide | 86 | $554 | $6 |
| Diltiazem 24hr Er | 18 | $483 | $27 |
| Isosorbide Mononitrate Er | 23 | $472 | $21 |
| Nystatin | 13 | $414 | $32 |
| Acyclovir | 20 | $345 | $17 |
| Warfarin | 21 | $308 | $15 |
| Sulfamethoxazole-Trimethoprim | 22 | $304 | $14 |
| Clopidogrel | 13 | $289 | $22 |
| Tamsulosin | 26 | $280 | $11 |
| Famotidine | 36 | $269 | $7 |
| Omeprazole | 14 | $196 | $14 |
| Prednisone | 28 | $154 | $6 |
| Pravastatin | 15 | $154 | $10 |
| Chlorthalidone | 15 | $101 | $7 |
| Alendronate | 13 | $42 | $3 |
2020: 46 drugs
| Entresto | 73 | $77,140 | $1,057 |
| Eliquis | 55 | $43,537 | $792 |
| Zortress | 21 | $28,154 | $1,341 |
| Sirolimus | 36 | $14,977 | $416 |
| Everolimus | 12 | $14,216 | $1,185 |
| Tacrolimus | 61 | $8,826 | $145 |
| Cyclosporine Modified | 49 | $6,471 | $132 |
| Bumetanide | 58 | $4,453 | $77 |
| Vascepa | 11 | $3,828 | $348 |
| Mycophenolate Mofetil | 18 | $3,355 | $186 |
| Eplerenone | 24 | $2,660 | $111 |
| Rosuvastatin | 65 | $2,215 | $34 |
| Potassium Chloride | 52 | $2,124 | $41 |
| Carvedilol | 163 | $1,850 | $11 |
| Ezetimibe | 34 | $1,502 | $44 |
| Metoprolol | 46 | $1,395 | $30 |
| Atorvastatin | 95 | $1,319 | $14 |
| Losartan | 83 | $1,295 | $16 |
| Lisinopril | 108 | $1,266 | $12 |
| Memantine | 13 | $1,089 | $84 |
| Diltiazem 24hr Er (Cd) | 14 | $1,070 | $76 |
| Pantoprazole | 82 | $992 | $12 |
| Isosorbide Mononitrate Er | 54 | $963 | $18 |
| Digoxin | 22 | $810 | $37 |
| Spironolactone | 106 | $800 | $8 |
| Hydralazine | 38 | $690 | $18 |
| Levothyroxine | 41 | $629 | $15 |
| Nystatin | 16 | $602 | $38 |
| Pravastatin | 47 | $547 | $12 |
| Furosemide | 106 | $515 | $5 |
| Diltiazem 24hr Er | 15 | $501 | $33 |
| Warfarin | 38 | $490 | $13 |
| Clopidogrel | 22 | $486 | $22 |
| Famotidine | 62 | $443 | $7 |
| Nitrostat | 12 | $424 | $35 |
| Amlodipine Besylate | 66 | $416 | $6 |
| Valsartan | 12 | $365 | $30 |
| Tamsulosin | 37 | $305 | $8 |
| Omeprazole | 20 | $297 | $15 |
| Sulfamethoxazole-Trimethoprim | 23 | $217 | $9 |
| Acyclovir | 21 | $214 | $10 |
| Chlorthalidone | 12 | $125 | $10 |
| Gabapentin | 13 | $118 | $9 |
| Prednisone | 13 | $73 | $6 |
| Clonidine | 13 | $72 | $6 |
| Fluoxetine | 11 | $20 | $2 |
2019: 47 drugs
| Entresto | 66 | $56,569 | $857 |
| Eliquis | 61 | $38,716 | $635 |
| Zortress | 20 | $37,673 | $1,884 |
| Sirolimus | 48 | $36,577 | $762 |
| Mycophenolic Acid | 20 | $11,599 | $580 |
| Tacrolimus | 96 | $8,865 | $92 |
| Bumetanide | 62 | $5,861 | $95 |
| Cyclosporine Modified | 21 | $3,927 | $187 |
| Envarsus Xr | 17 | $3,742 | $220 |
| Eplerenone | 16 | $2,817 | $176 |
| Potassium Chloride | 64 | $2,708 | $42 |
| Rosuvastatin | 47 | $2,495 | $53 |
| Mycophenolate Mofetil | 18 | $2,279 | $127 |
| Metoprolol | 63 | $1,943 | $31 |
| Carvedilol | 143 | $1,875 | $13 |
| Digoxin | 43 | $1,698 | $39 |
| Atorvastatin | 109 | $1,633 | $15 |
| Losartan | 79 | $1,403 | $18 |
| Spironolactone | 100 | $1,129 | $11 |
| Pravastatin | 86 | $1,067 | $12 |
| Gabapentin | 18 | $896 | $50 |
| Tamsulosin | 54 | $869 | $16 |
| Lisinopril | 64 | $770 | $12 |
| Hydralazine | 39 | $766 | $20 |
| Diltiazem 24hr Er (Cd) | 17 | $692 | $41 |
| Furosemide | 117 | $679 | $6 |
| Levothyroxine | 47 | $637 | $14 |
| Amiodarone | 19 | $626 | $33 |
| Warfarin | 39 | $623 | $16 |
| Ezetimibe | 13 | $531 | $41 |
| Pantoprazole | 42 | $525 | $12 |
| Isosorbide Mononitrate Er | 23 | $521 | $23 |
| Amlodipine Besylate | 75 | $376 | $5 |
| Famotidine | 48 | $364 | $8 |
| Allopurinol | 27 | $359 | $13 |
| Torsemide | 13 | $354 | $27 |
| Cephalexin | 12 | $311 | $26 |
| Clopidogrel | 25 | $238 | $10 |
| Sulfamethoxazole-Trimethoprim | 39 | $228 | $6 |
| Clonidine | 25 | $175 | $7 |
| Acyclovir | 13 | $173 | $13 |
| Sertraline | 16 | $156 | $10 |
| Prednisone | 27 | $126 | $5 |
| Omeprazole | 13 | $121 | $9 |
| Glipizide | 23 | $109 | $5 |
| Hydrochlorothiazide | 31 | $92 | $3 |
| Amoxicillin | 11 | $17 | $2 |
2018: 47 drugs
| Zortress | 12 | $33,342 | $2,778 |
| Sirolimus | 51 | $29,649 | $581 |
| Tacrolimus | 113 | $11,617 | $103 |
| Eliquis | 20 | $8,580 | $429 |
| Valganciclovir | 13 | $7,652 | $589 |
| Bumetanide | 56 | $5,489 | $98 |
| Mycophenolate Mofetil | 38 | $4,737 | $125 |
| Cyclosporine Modified | 28 | $4,012 | $143 |
| Nexium | 15 | $3,758 | $251 |
| Potassium Chloride | 47 | $3,098 | $66 |
| Pravastatin | 129 | $2,215 | $17 |
| Rosuvastatin | 28 | $1,561 | $56 |
| Ezetimibe | 12 | $1,217 | $101 |
| Omega-3 Acid Ethyl Esters | 12 | $1,142 | $95 |
| Metoprolol | 21 | $991 | $47 |
| Tamsulosin | 35 | $845 | $24 |
| Warfarin | 61 | $708 | $12 |
| Carvedilol | 51 | $637 | $12 |
| Gabapentin | 31 | $590 | $19 |
| Atorvastatin | 38 | $576 | $15 |
| Hydralazine | 21 | $549 | $26 |
| Levothyroxine | 34 | $521 | $15 |
| Spironolactone | 56 | $507 | $9 |
| Losartan | 35 | $468 | $13 |
| Amlodipine Besylate | 110 | $448 | $4 |
| Allopurinol | 36 | $438 | $12 |
| Pantoprazole | 50 | $430 | $9 |
| Prednisone | 41 | $410 | $10 |
| Lisinopril | 80 | $398 | $5 |
| Diltiazem 24hr Er (Cd) | 13 | $374 | $29 |
| Furosemide | 70 | $372 | $5 |
| Chlorthalidone | 13 | $358 | $28 |
| Clopidogrel | 32 | $335 | $10 |
| Clonidine | 28 | $330 | $12 |
| Ondansetron Odt | 12 | $272 | $23 |
| Ramipril | 12 | $247 | $21 |
| Lansoprazole | 11 | $243 | $22 |
| Simvastatin | 12 | $236 | $20 |
| Sulfamethoxazole-Trimethoprim | 36 | $216 | $6 |
| Omeprazole | 19 | $135 | $7 |
| Citalopram Hbr | 25 | $112 | $4 |
| Famotidine | 19 | $111 | $6 |
| Hydrochlorothiazide | 34 | $93 | $3 |
| Glipizide | 19 | $87 | $5 |
| Sertraline | 18 | $74 | $4 |
| Benazepril | 12 | $71 | $6 |
| Paroxetine | 11 | $42 | $4 |
2017: 47 drugs
| Tracleer | 11 | $112,869 | $10,261 |
| Adcirca | 29 | $103,246 | $3,560 |
| Sildenafil | 44 | $37,549 | $853 |
| Tacrolimus | 126 | $31,346 | $249 |
| Zetia | 39 | $18,426 | $472 |
| Mycophenolic Acid | 24 | $9,616 | $401 |
| Bumetanide | 49 | $8,906 | $182 |
| Sirolimus | 17 | $7,965 | $469 |
| Ezetimibe | 17 | $6,401 | $377 |
| Mycophenolate Mofetil | 66 | $5,947 | $90 |
| Potassium Chloride | 95 | $5,735 | $60 |
| Spiriva | 11 | $3,960 | $360 |
| Eplerenone | 22 | $3,867 | $176 |
| Pravastatin | 139 | $3,276 | $24 |
| Cyclosporine Modified | 11 | $2,174 | $198 |
| Atorvastatin | 86 | $1,823 | $21 |
| Carvedilol | 178 | $1,806 | $10 |
| Rosuvastatin | 24 | $1,599 | $67 |
| Metoprolol | 23 | $1,533 | $67 |
| Amiodarone | 19 | $1,467 | $77 |
| Warfarin | 110 | $1,392 | $13 |
| Pantoprazole | 105 | $1,387 | $13 |
| Klor-Con M20 | 17 | $1,248 | $73 |
| Sulfamethoxazole-Trimethoprim | 174 | $1,105 | $6 |
| Lisinopril | 132 | $1,011 | $8 |
| Digoxin | 20 | $981 | $49 |
| Furosemide | 131 | $971 | $7 |
| Metolazone | 15 | $891 | $59 |
| Allopurinol | 41 | $887 | $22 |
| Amlodipine Besylate | 103 | $884 | $9 |
| Spironolactone | 89 | $883 | $10 |
| Digox | 11 | $667 | $61 |
| Omeprazole | 36 | $589 | $16 |
| Famotidine | 44 | $581 | $13 |
| Tamsulosin | 14 | $509 | $36 |
| Gabapentin | 28 | $497 | $18 |
| Fenofibrate | 14 | $491 | $35 |
| Clonidine | 39 | $438 | $11 |
| Clopidogrel | 30 | $431 | $14 |
| Metoprolol | 28 | $390 | $14 |
| Losartan | 30 | $345 | $11 |
| Simvastatin | 29 | $222 | $8 |
| Prednisone | 19 | $207 | $11 |
| Valsartan | 18 | $173 | $10 |
| Amoxicillin | 16 | $136 | $9 |
| Jantoven | 11 | $132 | $12 |
| Hydrochlorothiazide | 37 | $99 | $3 |
2016: 54 drugs
| Letairis | 25 | $208,568 | $8,343 |
| Tracleer | 13 | $122,504 | $9,423 |
| Adcirca | 38 | $113,702 | $2,992 |
| Sildenafil | 21 | $29,315 | $1,396 |
| Zetia | 46 | $24,467 | $532 |
| Tacrolimus | 117 | $21,744 | $186 |
| Sirolimus | 20 | $19,445 | $972 |
| Valganciclovir | 14 | $15,811 | $1,129 |
| Mycophenolate Mofetil | 101 | $11,061 | $110 |
| Potassium Chloride | 98 | $9,472 | $97 |
| Neoral | 18 | $7,663 | $426 |
| Bumetanide | 31 | $7,295 | $235 |
| Eplerenone | 22 | $5,803 | $264 |
| Pravastatin | 205 | $4,477 | $22 |
| Gengraf | 12 | $3,250 | $271 |
| Doxycycline Hyclate | 11 | $2,702 | $246 |
| Atorvastatin | 121 | $2,589 | $21 |
| Dapsone | 25 | $2,102 | $84 |
| Carvedilol | 191 | $1,899 | $10 |
| Warfarin | 125 | $1,896 | $15 |
| Metolazone | 21 | $1,667 | $79 |
| Pantoprazole | 114 | $1,482 | $13 |
| Furosemide | 188 | $1,427 | $8 |
| Lisinopril | 173 | $1,367 | $8 |
| Sulfamethoxazole-Trimethoprim | 255 | $1,244 | $5 |
| Klor-Con M20 | 25 | $1,238 | $50 |
| Amiodarone | 23 | $1,232 | $54 |
| Amlodipine Besylate | 116 | $1,053 | $9 |
| Gabapentin | 16 | $1,020 | $64 |
| Diltiazem 24hr Er | 12 | $936 | $78 |
| Metoprolol | 21 | $786 | $37 |
| Digoxin | 15 | $749 | $50 |
| Omeprazole | 47 | $697 | $15 |
| Clonidine | 59 | $659 | $11 |
| Spironolactone | 52 | $637 | $12 |
| Allopurinol | 33 | $620 | $19 |
| Clopidogrel | 31 | $616 | $20 |
| Losartan | 50 | $564 | $11 |
| Azathioprine | 23 | $507 | $22 |
| Famotidine | 47 | $485 | $10 |
| Levothyroxine | 14 | $439 | $31 |
| Fenofibrate | 13 | $370 | $28 |
| Metoprolol | 34 | $322 | $9 |
| Repaglinide | 11 | $311 | $28 |
| Tamsulosin | 11 | $283 | $26 |
| Jantoven | 24 | $249 | $10 |
| Amoxicillin | 12 | $207 | $17 |
| Simvastatin | 28 | $171 | $6 |
| Gemfibrozil | 14 | $154 | $11 |
| Glimepiride | 13 | $129 | $10 |
| Sodium Chloride | 11 | $118 | $11 |
| Prednisone | 23 | $113 | $5 |
| Fluoxetine | 14 | $91 | $6 |
| Hydrochlorothiazide | 19 | $61 | $3 |
2015: 58 drugs
| Letairis | 35 | $258,700 | $7,391 |
| Tracleer | 12 | $99,139 | $8,262 |
| Adcirca | 39 | $89,795 | $2,302 |
| Sildenafil | 17 | $36,640 | $2,155 |
| Tacrolimus | 113 | $36,350 | $322 |
| Rapamune | 15 | $32,528 | $2,169 |
| Sirolimus | 17 | $32,278 | $1,899 |
| Zetia | 46 | $18,824 | $409 |
| Cellcept | 12 | $15,998 | $1,333 |
| Mycophenolate Mofetil | 89 | $8,050 | $90 |
| Neoral | 26 | $7,943 | $305 |
| Potassium Chloride | 91 | $7,233 | $79 |
| Pravastatin | 238 | $6,247 | $26 |
| Gengraf | 28 | $4,809 | $172 |
| Eplerenone | 11 | $4,244 | $386 |
| Doxycycline Hyclate | 16 | $3,676 | $230 |
| Bumetanide | 17 | $3,244 | $191 |
| Cyclosporine Modified | 14 | $2,664 | $190 |
| Atorvastatin | 95 | $2,106 | $22 |
| Klor-Con M20 | 27 | $1,854 | $69 |
| Warfarin | 95 | $1,727 | $18 |
| Azathioprine | 48 | $1,674 | $35 |
| Carvedilol | 201 | $1,583 | $8 |
| Diltiazem 24hr Er | 19 | $1,434 | $75 |
| Furosemide | 204 | $1,254 | $6 |
| Metolazone | 25 | $1,146 | $46 |
| Sulfamethoxazole-Trimethoprim | 243 | $1,061 | $4 |
| Lisinopril | 167 | $1,044 | $6 |
| Pantoprazole | 54 | $905 | $17 |
| Amiodarone | 21 | $861 | $41 |
| Digox | 11 | $769 | $70 |
| Omeprazole | 74 | $753 | $10 |
| Metoprolol | 16 | $679 | $42 |
| Amlodipine Besylate | 76 | $660 | $9 |
| Dapsone | 17 | $649 | $38 |
| Digoxin | 17 | $633 | $37 |
| Digitek | 11 | $623 | $57 |
| Clonidine | 69 | $619 | $9 |
| Allopurinol | 29 | $551 | $19 |
| Clopidogrel | 50 | $526 | $11 |
| Metoprolol | 56 | $456 | $8 |
| Losartan | 39 | $351 | $9 |
| Famotidine | 41 | $333 | $8 |
| Sertraline | 14 | $318 | $23 |
| Spironolactone | 34 | $315 | $9 |
| Tamsulosin | 14 | $299 | $21 |
| Levothyroxine | 15 | $298 | $20 |
| Simvastatin | 35 | $254 | $7 |
| Baclofen | 12 | $254 | $21 |
| Gemfibrozil | 25 | $227 | $9 |
| Jantoven | 15 | $173 | $12 |
| Amoxicillin | 13 | $163 | $13 |
| Isosorbide Mononitrate Er | 14 | $143 | $10 |
| Prednisone | 23 | $134 | $6 |
| Irbesartan | 12 | $112 | $9 |
| Hydrochlorothiazide | 11 | $104 | $9 |
| Glimepiride | 11 | $102 | $9 |
| Diltiazem | 11 | $63 | $6 |
2014: 59 drugs
| Letairis | 29 | $202,516 | $6,983 |
| Tracleer | 21 | $157,534 | $7,502 |
| Adcirca | 37 | $75,394 | $2,038 |
| Tacrolimus | 131 | $55,573 | $424 |
| Sildenafil | 17 | $25,915 | $1,524 |
| Rapamune | 15 | $23,142 | $1,543 |
| Zetia | 56 | $17,078 | $305 |
| Cellcept | 11 | $13,612 | $1,237 |
| Mycophenolate Mofetil | 76 | $8,287 | $109 |
| Gengraf | 24 | $7,277 | $303 |
| Neoral | 33 | $7,212 | $219 |
| Doxycycline Hyclate | 19 | $6,683 | $352 |
| Pravastatin | 206 | $6,592 | $32 |
| Klor-Con M20 | 80 | $4,308 | $54 |
| Prograf | 17 | $4,185 | $246 |
| Potassium Chloride | 40 | $3,941 | $99 |
| Atorvastatin | 102 | $3,905 | $38 |
| Lyrica | 14 | $3,871 | $276 |
| Bumetanide | 32 | $3,505 | $110 |
| Lipitor | 13 | $3,069 | $236 |
| Carvedilol | 181 | $2,283 | $13 |
| Digoxin | 43 | $2,230 | $52 |
| Coreg Cr | 11 | $1,923 | $175 |
| Furosemide | 219 | $1,811 | $8 |
| Warfarin | 119 | $1,527 | $13 |
| Digox | 31 | $1,388 | $45 |
| Amlodipine Besylate | 118 | $1,359 | $12 |
| Calcium Acetate | 11 | $1,338 | $122 |
| Pantoprazole | 32 | $1,326 | $41 |
| Omeprazole | 95 | $1,208 | $13 |
| Sulfamethoxazole-Trimethoprim | 281 | $1,185 | $4 |
| Fenofibrate | 12 | $1,160 | $97 |
| Azathioprine | 53 | $1,154 | $22 |
| Lisinopril | 167 | $1,072 | $6 |
| Metolazone | 36 | $1,070 | $30 |
| Clopidogrel | 40 | $922 | $23 |
| Metoprolol | 16 | $894 | $56 |
| Hydralazine | 29 | $811 | $28 |
| Clonidine | 59 | $778 | $13 |
| Spironolactone | 57 | $767 | $13 |
| Dapsone | 20 | $701 | $35 |
| Simvastatin | 46 | $688 | $15 |
| Sertraline | 27 | $608 | $23 |
| Losartan | 59 | $590 | $10 |
| Allopurinol | 51 | $490 | $10 |
| Gabapentin | 18 | $444 | $25 |
| Isosorbide Mononitrate Er | 15 | $423 | $28 |
| Metoprolol | 61 | $397 | $7 |
| Tamsulosin | 18 | $368 | $20 |
| Amoxicillin | 20 | $285 | $14 |
| Famotidine | 43 | $276 | $6 |
| Levothyroxine | 24 | $259 | $11 |
| Amiodarone | 18 | $254 | $14 |
| Prednisone | 35 | $201 | $6 |
| Baclofen | 12 | $188 | $16 |
| Jantoven | 23 | $187 | $8 |
| Hydrochlorothiazide | 18 | $170 | $9 |
| Irbesartan | 12 | $156 | $13 |
| Gemfibrozil | 13 | $87 | $7 |
2013: 64 drugs
| Tracleer | 24 | $164,552 | $6,856 |
| Letairis | 18 | $118,995 | $6,611 |
| Adcirca | 33 | $57,211 | $1,734 |
| Tacrolimus | 69 | $37,256 | $540 |
| Rapamune | 15 | $15,475 | $1,032 |
| Cellcept | 13 | $14,610 | $1,124 |
| Myfortic | 22 | $14,065 | $639 |
| Mycophenolate Mofetil | 98 | $11,813 | $121 |
| Zetia | 45 | $10,811 | $240 |
| Prograf | 34 | $10,417 | $306 |
| Neoral | 33 | $7,825 | $237 |
| Klor-Con M20 | 86 | $7,752 | $90 |
| Gengraf | 24 | $6,167 | $257 |
| Diovan | 29 | $6,103 | $210 |
| Pravastatin | 250 | $4,681 | $19 |
| Atorvastatin | 78 | $3,695 | $47 |
| Pradaxa | 12 | $3,206 | $267 |
| Carvedilol | 166 | $2,637 | $16 |
| Clopidogrel | 39 | $2,493 | $64 |
| Potassium Chloride | 40 | $2,407 | $60 |
| Lisinopril | 201 | $1,872 | $9 |
| Coreg Cr | 12 | $1,829 | $152 |
| Warfarin | 139 | $1,815 | $13 |
| Fenofibrate | 13 | $1,728 | $133 |
| Furosemide | 196 | $1,680 | $9 |
| Amlodipine Besylate | 108 | $1,650 | $15 |
| Bumetanide | 47 | $1,633 | $35 |
| Metoprolol | 22 | $1,574 | $72 |
| Omeprazole | 94 | $1,541 | $16 |
| Calcium Acetate | 14 | $1,496 | $107 |
| Sulfamethoxazole-Trimethoprim | 266 | $1,154 | $4 |
| Simvastatin | 61 | $1,024 | $17 |
| Amiodarone | 20 | $1,021 | $51 |
| Clonidine | 60 | $922 | $15 |
| Pantoprazole | 30 | $876 | $29 |
| Losartan | 48 | $820 | $17 |
| Hydralazine | 30 | $749 | $25 |
| Calcitriol | 12 | $733 | $61 |
| Azathioprine | 30 | $695 | $23 |
| Sertraline | 18 | $549 | $30 |
| Spironolactone | 32 | $545 | $17 |
| Metolazone | 19 | $505 | $27 |
| Metoprolol | 59 | $498 | $8 |
| Isosorbide Mononitrate Er | 32 | $446 | $14 |
| Dapsone | 13 | $437 | $34 |
| Digox | 25 | $404 | $16 |
| Allopurinol | 41 | $362 | $9 |
| Tamsulosin | 12 | $341 | $28 |
| Famotidine | 49 | $329 | $7 |
| Pacerone | 13 | $328 | $25 |
| Gemfibrozil | 12 | $287 | $24 |
| Bupropion Hcl Sr | 11 | $272 | $25 |
| Gabapentin | 18 | $243 | $14 |
| Irbesartan | 19 | $235 | $12 |
| Digoxin | 24 | $230 | $10 |
| Diltiazem 24hr Cd | 12 | $217 | $18 |
| Zolpidem | 18 | $178 | $10 |
| Levothyroxine | 23 | $174 | $8 |
| Amoxicillin | 14 | $174 | $12 |
| Jantoven | 23 | $170 | $7 |
| Hydrochlorothiazide | 25 | $93 | $4 |
| Prednisone | 23 | $92 | $4 |
| Baclofen | 11 | $92 | $8 |
| Diltiazem | 19 | $72 | $4 |
Money from drug and device companies
$53,050 in 2025
| 2025 | 7 | 85 | $43,375 | $53,050 |
| 2024 | 6 | 49 | $17,500 | $22,761 |
| 2023 | 5 | 15 | $5,625 | $5,940 |
| 2022 | 5 | 27 | $14,750 | $17,567 |
| 2021 | 4 | 62 | $36,100 | $38,439 |
| 2020 | 3 | 13 | $17,000 | $17,218 |
| 2019 | 2 | 55 | $34,250 | $40,097 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CVRx | Barostim Neo System | $26,778 | 55 payments
|
| Abiomed | None | $10,678 | 10 payments
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $7,273 | 6 payments
|
| BrioHealth Solutions | Briovad | $6,250 | 6 payments
|
| Paragonix Technologies | Sherpapak | $1,868 | 5 payments
|
| Edwards Lifesciences | None | $130 | 2 payments
|
See all 85 published payments
| Abbott Laboratories | Consulting · 2025-12-23 | Thoratec Heartmate 3 Lvas Implant Kit | $1,000 |
| BrioHealth Solutions | Consulting · 2025-12-10 | Briovad | $1,250 |
| BrioHealth Solutions | Consulting · 2025-12-10 | Briovad | $750 |
| BrioHealth Solutions | Consulting · 2025-12-01 | Briovad | $1,250 |
| CVRx | Travel · 2025-11-25 | Barostim Neo System | $379 |
| CVRx | Meals · 2025-11-25 | Barostim Neo System | $25 |
| CVRx | Consulting · 2025-11-20 | Barostim Neo System | $12,125 |
| CVRx | Meals · 2025-10-22 | Barostim Neo System | $25 |
| CVRx | Meals · 2025-10-15 | Barostim Neo System | $30 |
| CVRx | Meals · 2025-10-14 | Barostim Neo System | $42 |
| CVRx | Meals · 2025-10-13 | Barostim Neo System | $35 |
| CVRx | Meals · 2025-10-13 | Barostim Neo System | $47 |
| CVRx | Meals · 2025-10-13 | Barostim Neo System | $72 |
| CVRx | Travel · 2025-10-13 | Barostim Neo System | $499 |
| CVRx | Meals · 2025-10-11 | Barostim Neo System | $24 |
| CVRx | Meals · 2025-10-11 | Barostim Neo System | $131 |
| CVRx | Meals · 2025-09-28 | Barostim Neo System | $71 |
| Abbott Laboratories | Consulting · 2025-09-04 | Thoratec Heartmate 3 Lvas Implant Kit | $3,375 |
| CVRx | Travel · 2025-08-26 | Barostim Neo System | $68 |
| CVRx | Travel · 2025-08-26 | Barostim Neo System | $313 |
| CVRx | Travel · 2025-08-26 | Barostim Neo System | $340 |
| BrioHealth Solutions | Consulting · 2025-07-23 | Briovad | $1,000 |
| Merck Sharp & Dohme | Meals · 2025-07-20 | None | $73 |
| Edwards Lifesciences | Meals · 2025-07-18 | None | $38 |
| Edwards Lifesciences | Meals · 2025-07-18 | None | $91 |
| CVRx | Meals · 2025-07-14 | Barostim Neo System | $43 |
| CVRx | Travel · 2025-07-10 | Barostim Neo System | $244 |
| CVRx | Meals · 2025-07-10 | Barostim Neo System | $76 |
| CVRx | Consulting · 2025-07-10 | Barostim Neo System | $4,000 |
| BrioHealth Solutions | Consulting · 2025-07-01 | Briovad | $1,000 |
| CVRx | Meals · 2025-06-03 | Barostim Neo System | $204 |
| Abiomed | Consulting · 2025-05-15 | None | $9,250 |
| CVRx | Meals · 2025-05-13 | Barostim Neo System | $78 |
| CVRx | Meals · 2025-05-13 | Barostim Neo System | $113 |
| CVRx | Travel · 2025-05-09 | Barostim Neo System | $430 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $31 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $78 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $78 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $102 |
| CVRx | Meals · 2025-05-09 | Barostim Neo System | $292 |
| CVRx | Travel · 2025-05-08 | Barostim Neo System | $26 |
| CVRx | Travel · 2025-05-08 | Barostim Neo System | $26 |
| CVRx | Travel · 2025-05-08 | Barostim Neo System | $323 |
| CVRx | Meals · 2025-05-03 | Barostim Neo System | $57 |
| CVRx | Meals · 2025-05-03 | Barostim Neo System | $127 |
| CVRx | Meals · 2025-05-02 | Barostim Neo System | $24 |
| CVRx | Meals · 2025-04-28 | Barostim Neo System | $33 |
| CVRx | Meals · 2025-04-27 | Barostim Neo System | $60 |
| CVRx | Travel · 2025-04-22 | Barostim Neo System | $26 |
| CVRx | Travel · 2025-04-22 | Barostim Neo System | $397 |
| BrioHealth Solutions | Consulting · 2025-04-17 | Briovad | $1,000 |
| CVRx | Travel · 2025-04-10 | Barostim Neo System | $243 |
| CVRx | Meals · 2025-04-10 | Barostim Neo System | $51 |
| CVRx | Meals · 2025-04-10 | Barostim Neo System | $81 |
| CVRx | Meals · 2025-04-10 | Barostim Neo System | $83 |
| Paragonix Technologies | Travel · 2025-04-04 | Sherpapak | $171 |
| Paragonix Technologies | Travel · 2025-04-04 | Sherpapak | $84 |
| Paragonix Technologies | Travel · 2025-04-04 | Sherpapak | $176 |
| Paragonix Technologies | Travel · 2025-04-04 | Sherpapak | $437 |
| Paragonix Technologies | Honoraria · 2025-04-04 | Sherpapak | $1,000 |
| CVRx | Travel · 2025-03-27 | Barostim Neo System | $34 |
| CVRx | Travel · 2025-03-27 | Barostim Neo System | $499 |
| CVRx | Meals · 2025-03-17 | Barostim Neo System | $9 |
| CVRx | Meals · 2025-03-15 | Barostim Neo System | $35 |
| CVRx | Meals · 2025-03-14 | Barostim Neo System | $52 |
| CVRx | Meals · 2025-03-14 | Barostim Neo System | $78 |
| CVRx | Meals · 2025-03-13 | Barostim Neo System | $24 |
| Abbott Laboratories | Consulting · 2025-03-13 | Thoratec Heartmate 3 Lvas Implant Kit | $500 |
| CVRx | Consulting · 2025-03-07 | Barostim Neo System | $3,625 |
| CVRx | Travel · 2025-02-27 | Barostim Neo System | $34 |
| CVRx | Travel · 2025-02-27 | Barostim Neo System | $261 |
| CVRx | Travel · 2025-02-26 | Barostim Neo System | $34 |
| CVRx | Travel · 2025-02-26 | Barostim Neo System | $543 |
| Abbott Laboratories | Meals · 2025-02-17 | Thoratec Heartmate 3 Lvas Implant Kit | $148 |
| Abbott Laboratories | Consulting · 2025-02-06 | Thoratec Heartmate 3 Lvas Implant Kit | $1,875 |
| Abiomed | Meals · 2025-01-15 | None | $36 |
| Abiomed | Meals · 2025-01-14 | None | $65 |
| Abiomed | Meals · 2025-01-14 | None | $43 |
| Abiomed | Travel · 2025-01-14 | None | $341 |
| Abiomed | Meals · 2025-01-14 | None | $34 |
| Abiomed | Meals · 2025-01-13 | None | $148 |
| Abiomed | Travel · 2025-01-13 | None | $426 |
| Abiomed | Travel · 2025-01-13 | None | $228 |
| Abiomed | Meals · 2025-01-13 | None | $107 |
| Abbott Laboratories | Consulting · 2025-01-09 | Mitraclip | $375 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $22,761
| CVRx | Barostim Neo System | $17,722 | 29 payments
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $4,375 | 11 payments
|
| Paragonix Technologies | Sherpapak | $381 | 3 payments
|
| Endotronix | Cordella Pulomonary Artery Pressure Sensor | $136 | 1 payment
|
| Merck Sharp & Dohme | None | $108 | 1 payment
|
| Medtronic | Venaseal | $40 | 2 payments
|
2023: $5,940
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $5,794 | 11 payments
|
| Abiomed | Impella | $65 | 1 payment
|
| Endotronix | Cordella Pulomonary Artery Pressure Sensor | $50 | 1 payment
|
| Edwards Lifesciences | None | $21 | 1 payment
|
| CVRx | Barostim Neo System | $11 | 1 payment
|
2022: $17,567
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $11,436 | 22 payments
|
| Medtronic | None | $4,500 | 2 payments
|
| Paragonix Technologies | Paragonix Sherpapak Cardiac Transport System | $1,500 | 1 payment
|
| Abiomed | Impella | $113 | 1 payment
|
| Daxor | Bva-100 | $18 | 1 payment
|
2021: $38,439
| Abbott Laboratories | Heartmate 3 Left Ventricular Assist Device | $29,203 | 55 payments
|
| Abiomed | Impella | $4,285 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $4,200 | 2 payments
|
| Medtronic | Heartware Hvad | $750 | 1 payment
|
2020: $17,218
| Abbott Laboratories | Cardiomems Hf System | $16,093 | 11 payments
|
| Paragonix Technologies | Sherpacool | $1,000 | 1 payment
|
| Medtronic Vascular | Heartware Hvad | $125 | 1 payment
|
2019: $40,097
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $25,999 | 30 payments
|
| Medtronic Vascular | Heartware Hvad | $14,098 | 25 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ENDOTRONIX, INC. · Proactive-Hf · 2020 | Their institution | $12,477 |
| ENDOTRONIX, INC. · Proactive-Hf · 2021 | Their institution | $9,935 |
| Medtronic Vascular, Inc. · Psr-Mcs · 2019 | This clinician | $2,000 |
| Medtronic, Inc. · Dt Pas · 2021 | This clinician | $1,000 |
| Medtronic Vascular, Inc. · Dt Pas · 2020 | This clinician | $600 |
| Medtronic, Inc. · Psr-Mcs · 2021 | This clinician | $500 |
| AstraZeneca Pharmaceuticals LP · A Phase II Randomised Double-Blind Placebo Controlled Parallel-Group Multicentre Three Month Duration Potassium Reduction Initiative To Optimize Raas Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure (Prioritize Hf) · 2020 | Their institution | $317 |
| Medtronic, Inc. · Psr-Mcs · 2022 | This clinician | $250 |
| Medtronic, Inc. · Psr-Mcs · 2024 | This clinician | $250 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1952377582
- Licence
- CA C150673California C150673: Current · expires 2027-06-30
- Trained
- University of Chicago, Pritzker School of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- PA 101150883
- Taxonomy
- Federal specialty code 207RA0001X (207RA0001X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-02-24
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.